One local biotech fund manager said he is not interested in Prima given it has to undertake a three-year clinical trial for C-Vac. “Also its ovarian cancer treatment might not be relevant in a few years with newer and better treatments coming to market.”
How are they going to get to market with new treatments before they do preclincal, ph i,ii & iii trials...before Prima....Magic Wand!
All good with CVac but phii results need a big +ve to win over this market!
DYOR!
today's fin review, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.0¢ | 31.5¢ | $502.0K | 1.580M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1658 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 21734 | 3 |
View Market Depth
| Last trade - 15.59pm 11/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |